Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing

NCT07281014 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Placebo
DRUG: Spironolactone 25mg
DRUG: Aldosterone

Sponsor

Yale University

Collaborators

[object Object]